SILVITELLI, MARIA
SILVITELLI, MARIA
Mostra
records
Risultati 1 - 2 di 2 (tempo di esecuzione: 0.006 secondi).
Early combination of sotrovimab with nirmatrelvir/ritonavir or remdesivir is associated with low rate of persisting SARS CoV-2 infection in immunocompromised outpatients with mild-to-moderate COVID-19: a prospective single-centre study
2025 Gentile, I.; Viceconte, G.; Cuccurullo, F.; Pietroluongo, D.; D'Agostino, A.; Silvitelli, M.; Mercinelli, S.; Scotto, R.; Grimaldi, F.; Palmieri, S.; Gravetti, A.; Trastulli, F.; Moccia, M.; Buonomo, A. R.
Optimizing COVID-19 treatment in immunocompromised patients: early combination therapy with remdesivir, nirmatrelvir/ritonavir and sotrovimab
2023 Gentile, I.; Foggia, M.; Silvitelli, M.; Sardanelli, A.; Cattaneo, L.; Viceconte, G.
| Titolo | Tipologia | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|---|
| Early combination of sotrovimab with nirmatrelvir/ritonavir or remdesivir is associated with low rate of persisting SARS CoV-2 infection in immunocompromised outpatients with mild-to-moderate COVID-19: a prospective single-centre study | 1.1 Articolo in rivista | 2025 | Gentile, I.; Viceconte, G.; Cuccurullo, F.; Pietroluongo, D.; D'Agostino, A.; Silvitelli, M.; Mercinelli, S.; Scotto, R.; Grimaldi, F.; Palmieri, S.; Gravetti, A.; Trastulli, F.; Moccia, M.; Buonomo, A. R. | |
| Optimizing COVID-19 treatment in immunocompromised patients: early combination therapy with remdesivir, nirmatrelvir/ritonavir and sotrovimab | 1.1 Articolo in rivista | 2023 | Gentile, I.; Foggia, M.; Silvitelli, M.; Sardanelli, A.; Cattaneo, L.; Viceconte, G. |